Hyundai Bioscience Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Hyundai Bioscience Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Efficacy of CP-PCA07 in Combination With Enzalutamide in Patients With Castration-Resistant Prostate Cancer (NCT07683013) | Hyundai Bioscience Co., Ltd. | 2026-07-01 |
| A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2) (NCT07576868) | Hyundai Bioscience Co., Ltd. | 2026-04-09 |
Track Hyundai Bioscience Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.